Unnamed: 0,title,date,stock,sentiment
218149.0,"China Biologic Products Reports Xinjiang Deyuan Bioengineering Materially Breached Strategic Cooperation With Co. By Entering Plasma Supply Deals With Southern Shuanglin Bio-Pharmacy, Co. Will Take All Necessary Measures To Protect Its Rights",2020-05-20 16:48:00-04:00,CBPO,positive
218150.0,"China Biologic Products Q1 EPS $1.560 Beats $1.380 Estimate, Sales $162.600M Up From $129.784M YoY",2020-05-20 16:32:00-04:00,CBPO,neutral
218151.0,"The Daily Biotech Pulse: Aldeyra Jumps Into COVID-19 Drug Fray, FDA Nod For Myriad's Companion Diagnostic Test",2020-05-20 08:12:00-04:00,CBPO,neutral
218152.0,"The Week Ahead In Biotech: Aquestive Awaits FDA Decision, Earnings Flow Slows",2020-05-17 12:30:00-04:00,CBPO,positive
218153.0,"China Biologic Products Q4 EPS $0.53 Down From $0.76 YoY, Sales $102.2M Miss $125.3M Estimate",2020-03-12 17:01:00-04:00,CBPO,negative
218154.0,"The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO",2020-03-12 07:37:00-04:00,CBPO,negative
218155.0,"The Week Ahead In Biotech (March 8-14): Bristol-Myers Awaits FDA Nod For Liver Cancer Combo Therapy, Earnings Flow Continues",2020-03-08 16:14:00-04:00,CBPO,negative
218156.0,"The Daily Biotech Pulse: Amarin Gets Unanimous Backing For Vascepa Expansion, BeiGene's Blood Cancer Drug Gets Approval",2019-11-15 07:08:00-05:00,CBPO,negative
218157.0,Stocks That Hit 52-Week Highs On Thursday,2019-11-14 10:09:00-05:00,CBPO,neutral
218158.0,"The Daily Biotech Pulse: Amarin Braces For Vascepa Adcom Verdict, Biotechs On A Fundraising Spree, Zosano Makes Progress With Migraine Drug Filing",2019-11-14 08:07:00-05:00,CBPO,positive
218159.0,"China Biologic Products Q3 EPS $1.4 Beats $0.88 Estimate, Sales $136.1M Beat $127M Estimate",2019-11-13 16:45:00-05:00,CBPO,neutral
218160.0,"Earnings Scheduled For November 13, 2019",2019-11-13 03:58:00-05:00,CBPO,neutral
218161.0,"The Daily Biotech Pulse: FDA Panel Backs Shionogi's Antibiotic, Hepion Surges On Data Publication, Innate Pharma IPO",2019-10-17 07:39:00-04:00,CBPO,negative
218162.0,China Biologic Forms Special Committee To Review Going Private Proposal,2019-09-24 08:13:00-04:00,CBPO,positive
218163.0,24 Stocks Moving in Tuesday's Pre-Market Session,2019-09-24 07:45:00-04:00,CBPO,neutral
218164.0,"The Daily Biotech Pulse: FDA Approves Merck HIV Drugs, Five Prime CEO Quits, HTG Molecular Announces Secondary Offering",2019-09-20 07:46:00-04:00,CBPO,positive
218165.0,46 Biggest Movers From Yesterday,2019-09-20 04:45:00-04:00,CBPO,neutral
218166.0,32 Stocks Moving In Thursday's Mid-Day Session,2019-09-19 12:54:00-04:00,CBPO,neutral
218167.0,China Biologic Products shares are trading higher after the company announced it received an offer to take the company private for $120 per share.,2019-09-19 12:21:00-04:00,CBPO,positive
218168.0,"The Daily Biotech Pulse: China Biologics Receives Buyout Offer, Provention Bio Offering, Exagen IPO",2019-09-19 07:39:00-04:00,CBPO,neutral
218169.0,China Biologic Products shares are trading higher after the company announced it received an offer to take the company private for $120 per share.,2019-09-18 16:37:00-04:00,CBPO,positive
218170.0,"China Biologic Shares Resume Trade, Up 11.4%",2019-09-18 16:32:00-04:00,CBPO,positive
218171.0,"UPDATE: China Biologic Offer From Beachhead, CITIC, PW Medtech, Parfield, HH Sum-XXI, V-Sciences",2019-09-18 16:02:00-04:00,CBPO,neutral
218172.0,China Biologic Reports Receipt Of Prelim. Non-Binding Go-Private Offer At $120/Share In Cash,2019-09-18 16:02:00-04:00,CBPO,neutral
218173.0,China Biologics Products Shares Halted News Pending,2019-09-18 16:01:00-04:00,CBPO,positive
218174.0,"The Daily Biotech Pulse: Cheery Results For Sage's Depression Drug, UniQure Offering, Axsome Aces Study Of Headache Drug",2019-09-05 08:12:00-04:00,CBPO,neutral
218175.0,"The Daily Biotech Pulse: Puma Leaps, Aerie Borrows, Hepion Back In Nasdaq's Good Books",2019-09-04 07:08:00-04:00,CBPO,positive
218176.0,"China Biologic Products Q2 EPS $1.24 Beats $1.03 Estimate, Sales $135.7M Beat $122M Estimate",2019-08-05 17:02:00-04:00,CBPO,neutral
218177.0,"China Biologic Products Q1 EPS $1.11 Beats $1 Estimate, Sales $129.784M Beat $122M Estimate",2019-05-10 16:36:00-04:00,CBPO,neutral
218178.0,"Earnings Scheduled For May 10, 2019",2019-05-10 04:17:00-04:00,CBPO,neutral
218179.0,"Benzinga's Top Upgrades, Downgrades For March 11, 2019",2019-03-11 09:10:00-04:00,CBPO,positive
218180.0,Jefferies Downgrades China Biologic Products to Underperform,2019-03-11 07:03:00-04:00,CBPO,neutral
218181.0,26 Stocks Moving In Thursday's Pre-Market Session,2019-03-07 08:01:00-05:00,CBPO,neutral
218182.0,"Daily Biotech Pulse: Allergan's Depression Drug Flunks Late-Stage Trial, Apellis Offering, ShockWave Medical IPO",2019-03-07 07:48:00-05:00,CBPO,negative
218183.0,China Biologic Products On Mar. 4 Added $100M To Buyback,2019-03-06 17:03:00-05:00,CBPO,neutral
218184.0,"China Biologic Products Q4 Adj. EPS $0.76 vs $1.29 Estimate, Sales $114.9M vs $244.01M Estimate",2019-03-06 17:03:00-05:00,CBPO,neutral
218185.0,"Earnings Scheduled For March 6, 2019",2019-03-06 04:02:00-05:00,CBPO,neutral
218186.0,China Biologic Products Shareholder David Gao Makes Statement Following Decision by the Grand Court of the Cayman Islands,2018-12-17 10:07:00-05:00,CBPO,positive
218187.0,China Biologic Reports Dismissal Of Suit Filed In Cayman Islands By Former Chair,2018-12-14 08:14:00-05:00,CBPO,neutral
218188.0,"Benzinga's Top Upgrades, Downgrades For November 5, 2018",2018-11-05 09:05:00-05:00,CBPO,positive
218189.0,"Morgan Stanley Downgrades China Biologic Products to Equal-Weight, Announces $84 Price Target",2018-11-05 06:16:00-05:00,CBPO,neutral
218190.0,"China Biologic Products, Inc. Q3 EPS $0.96 Misses $1.29 Estimate, Sales $119.107M Up From $99.561M YoY",2018-11-01 17:38:00-04:00,CBPO,negative
218191.0,"Stocks Which Set New 52-Week Low Friday, October 26th",2018-10-29 09:56:00-04:00,CBPO,negative
218192.0,"Stocks Which Set New 52-Week Low Yesterday, October 23rd",2018-10-24 10:06:00-04:00,CBPO,negative
218193.0,"Stocks Which Set New 52-Week Low Yesterday, October 22nd",2018-10-23 09:54:00-04:00,CBPO,negative
218194.0,Hearing York Capital Has Called Out China Biologics Mgmt. To 'Undo' Its Private Placement,2018-10-04 12:50:00-04:00,CBPO,neutral
218195.0,China Biologic Products 13D From Centurium Capital Partners Shows New 7.9% Stake,2018-09-14 06:18:00-04:00,CBPO,neutral
218196.0,Bronte Capital Out With A Short Report On China Biologic Products,2018-09-05 09:57:00-04:00,CBPO,neutral
218197.0,"UPDATE: China Biologic Says It Is ""Prepared To Fend Off Meritless Lawsuits Like This And Will Take Actions To Seek Actual And Punitive Damages"" Against Former Chairman David Gao",2018-08-28 17:03:00-04:00,CBPO,negative
218198.0,China Biologic Responds To Lawsuit Filed In Cayman Islands By Former Chairman,2018-08-28 17:02:00-04:00,CBPO,negative
218199.0,44 Biggest Movers From Friday,2018-08-27 04:34:00-04:00,CBPO,neutral
218200.0,Mid-Afternoon Market Update: Crude Oil Up 1.75%; Splunk Shares Jump After Strong Q2 Earnings,2018-08-24 14:41:00-04:00,CBPO,positive
218201.0,40 Stocks Moving In Friday's Mid-Day Session,2018-08-24 12:47:00-04:00,CBPO,neutral
218202.0,Mid-Day Market Update: Dow Up Over 100 Points; Hibbett Sports Shares Drop Following Q2 Results,2018-08-24 12:40:00-04:00,CBPO,neutral
218203.0,"Leading Investor Group Issues Statement Following China Biologic's Dilutive Private Placement of Shares, Says They Are Deeply Disappointed That China Biologic's Board Decision",2018-08-24 12:36:00-04:00,CBPO,negative
218204.0,Mid-Morning Market Update: Markets Open Higher; Foot Locker Profit Beats Estimates,2018-08-24 10:14:00-04:00,CBPO,positive
218205.0,"China Biologic Products shares are down 12.3% to $88.50 after the company announced sale of 5.85 million new shares, totalling 14.9% of outstanding shares.",2018-08-24 09:22:00-04:00,CBPO,positive
218206.0,UPDATE: China Biologic Says Entered Deals For Sale Of 5.85M Common Shares For Gross Proceeds Of ~$590M,2018-08-24 08:03:00-04:00,CBPO,negative
218207.0,UPDATE: China Biologic Says Has Unanimously Determined Offer From CITIC Is Not In The Best Interests Of Shareholders,2018-08-24 08:02:00-04:00,CBPO,neutral
218208.0,China Biologic Products Reports Received Letter From CITIC Capital Withdrawing Its Prelim. Non-Binding Offer,2018-08-24 08:02:00-04:00,CBPO,neutral
218209.0,"China Biologic Reports Receipt Of Competing Non-Binding Purchase Proposal From Consortium Consisting Of Feng Tai, GL Sandrose, Etc., At $118/Share In Cash, Up From Prior Offer From CCRE Holdings At $110/Share In Cash",2018-08-21 08:17:00-04:00,CBPO,positive
218210.0,China Biologic Products Holdings Reports Receipt Of Competing Non-Binding Acquisition Consortium Proposal Of $118/Share In Cash,2018-08-21 08:04:00-04:00,CBPO,neutral
218211.0,41 Biggest Movers From Yesterday,2018-08-21 04:47:00-04:00,CBPO,neutral
218212.0,28 Stocks Moving In Monday's Mid-Day Session,2018-08-20 12:35:00-04:00,CBPO,neutral
218213.0,Mid-Morning Market Update: Markets Mostly Higher; PepsiCo To Buy SodaStream For $3.2 Billion,2018-08-20 10:10:00-04:00,CBPO,neutral
218214.0,China Biologic Products Holdings shares are up 14.7% in pre-market trading after the a leading investor group proposed to acquire the company for $118/share in cash.,2018-08-20 09:23:00-04:00,CBPO,positive
218215.0,Leading Investor Group Proposes to Acquire China Biologic Products for $118.00 Per Share in Cash,2018-08-20 08:32:00-04:00,CBPO,positive
218216.0,Hone In On Health Care In China With This New ETF,2018-08-16 11:49:00-04:00,CBPO,positive
218217.0,China Biologic Names Bing Li as New CEO,2018-08-13 08:07:00-04:00,CBPO,neutral
218218.0,"China Biologic Products Cuts FY18 Guidance, Now Sees Adj. EPS to Decrease 2-4% YoY, Citing Intensified Competition, and Persistent Regulatory Headwinds",2018-08-03 16:34:00-04:00,CBPO,negative
218219.0,"China Biologic Products Q2 EPS $1.17 Misses $1.39 Estimate, Sales $120.4M Miss $238.34M Estimate",2018-08-03 16:30:00-04:00,CBPO,negative
218220.0,"Earnings Scheduled For August 3, 2018",2018-08-03 04:22:00-04:00,CBPO,neutral
218221.0,China Biologic Products Shares Spike 1.1% As Traders Circulate Speculation Co. Approached By Several Private-Equity Firms Related To Possible Buyout,2018-07-10 12:16:00-04:00,CBPO,positive
218222.0,20 Stocks Moving In Tuesday's Pre-Market Session,2018-07-10 08:01:00-04:00,CBPO,neutral
218223.0,China Biologic Reports Receipt of Non-Binding Acquisition Proposal From CCRE Holidngs TO Acquire All Shares Of Co. Not Already Owned By CITIC For $110/Share Cash,2018-06-19 08:01:00-04:00,CBPO,positive
218224.0,60 Biggest Movers From Yesterday,2018-06-19 04:02:00-04:00,CBPO,neutral
218225.0,42 Stocks Moving In Monday's Mid-Day Session,2018-06-18 12:28:00-04:00,CBPO,neutral
218226.0,26 Stocks Moving In Monday's Pre-Market Session,2018-06-18 08:23:00-04:00,CBPO,neutral
218227.0,A Peek Into The Markets: US Stock Futures Point To A Lower Open,2018-06-18 07:11:00-04:00,CBPO,negative
218228.0,China Biologic Products Holdings Shares Rise 16% Premarket Following 13D Filing Indicating Non-Binding Offer for $110/Share,2018-06-18 06:49:00-04:00,CBPO,positive
218229.0,"CCRE Submitted Preliminary, Non-binding Letter to Acquire all Outstanding Share Capital of China Biologic Products Holdings Not Already Owned by CCRE for US$110 in Cash/Share",2018-06-18 06:18:00-04:00,CBPO,positive
218230.0,China Biologic Products Holdings Reports Received CFDA Clinical Trial Approval For Human Fibrin Sealant,2018-06-11 08:05:00-04:00,CBPO,positive
218231.0,Jefferies Downgrades China Biologic Products to Hold,2018-05-14 08:19:00-04:00,CBPO,neutral
218232.0,"China Biologic Sees FY18 Sales Growth 18-20%, Adj. Net Income Growth 16-18%",2018-05-04 16:43:00-04:00,CBPO,positive
218233.0,"China Biologic Products Q1 EPS $1.21 Misses $1.39 Estimate, Made $112.465M Sales",2018-05-04 16:31:00-04:00,CBPO,negative
218234.0,"China Biologic Sees FY18 Sales Growth 18-20%, Adj. EPS Growth 16-18% On YoY Basis",2018-02-28 17:01:00-05:00,CBPO,positive
218235.0,"China Biologic Reports Q4 Adj. EPS $0.90 vs $0.89 Est., Sales $90.1M vs $85.2M Est.",2018-02-28 17:01:00-05:00,CBPO,neutral
218236.0,PW Medtech Group Limited Reports 16.7% Stake in China Biologic Products Holdings -13D,2018-01-10 06:13:00-05:00,CBPO,negative
218237.0,"China Biologic Earlier Announced It Raised FY17 Sales Growth Outlook From 9-10% YoY To 10.5% YoY, Adj. EPS Growth Outlook Cut From 18-20% To 'Low Teens'",2018-01-08 12:19:00-05:00,CBPO,positive
218238.0,China Biologic Reports Received Operating Permit For New Collection Facility In Ju County Of Shandong Province,2017-12-15 08:30:00-05:00,CBPO,neutral
218239.0,"China Biologic Products Shares Up 7% Mon., Stock Up 15% Since Marking New 52-Week Low Fri. Morning; Shares Fell ~7% From Highs Over Thurs. Despite Better-Than-Expected Q3 Results, Reaffirmed Guidance On Wed. Afternoon",2017-11-06 11:00:00-05:00,CBPO,positive
218240.0,China Biologic Reaffirms FY17 Adj. Net Income Growth 18-20%,2017-11-01 17:16:00-04:00,CBPO,positive
218241.0,"China Biologic Reports Q3 Adj EPS $1.38 vs $1.19 Est., Sales $99.6M vs $96.5M Est.",2017-11-01 17:15:00-04:00,CBPO,neutral
218242.0,"China Biologic Products Reports Deal To Buy 80% Interest In TianXinFu From PWM, CBPO Will Issue ~5.52M Shares To PWM",2017-10-12 08:34:00-04:00,CBPO,positive
218243.0,China Biologic Receives China Food and Drug Administration Approval For Human Fibrinogen,2017-10-09 08:32:00-04:00,CBPO,positive
218244.0,"China Biologic Products Q2 Adj. EPS $1.35 vs $1.36 Est., Sales $89.3M vs $94.47M Est.",2017-08-02 17:04:00-04:00,CBPO,neutral
218245.0,"China Biologic Reports Q1 Adj. EPS $1.32 vs $1.24 Est., Sales $91.5M vs $85.1M Est.",2017-05-03 16:52:00-04:00,CBPO,neutral
218246.0,"China Biologic Reports Q4 Adj. EPS $0.95 vs. $0.84, Sales $77.6M vs. $76.2M Est.",2017-02-23 17:04:00-05:00,CBPO,neutral
218247.0,25 Stocks Moving In Tuesday's Pre-Market Session,2017-01-24 08:24:00-05:00,CBPO,neutral
218248.0,China Biologic Products Reiterates FY Forecast Of Total Sales Growth Of 22-24% In RMB Terms,2017-01-04 08:32:00-05:00,CBPO,positive
218249.0,"China Biologic Reports Q3 non-GAAP EPS $1.22 vs $1.05 Est, Sales $86.5M vs $88.46M Est",2016-11-02 17:01:00-04:00,CBPO,neutral
218250.0,China Biologic Products Reports Purchase of Full Ownership of Guizhou Taibang for ~$62.1M,2016-10-26 08:35:00-04:00,CBPO,neutral
218251.0,China Biologic Receives CFDA Clinical Trial Approval for Human Antithrombin III,2016-10-11 08:30:00-04:00,CBPO,positive
218252.0,China Biologic Reports Received CFDA Trial Approval for Human Coagulation Factor IX,2016-09-19 08:31:00-04:00,CBPO,positive
218253.0,"China Biologic Reports Q2 Adj EPS $1.26, Sales $91.4M",2016-08-04 17:19:00-04:00,CBPO,neutral
218254.0,China Biologic Prices 3.87M Shares at $110/Share,2016-03-02 09:18:00-05:00,CBPO,positive
218255.0,China Biologic Announces Secondary Offering of 3.5M Shares Of Common Stock,2016-03-01 17:55:00-05:00,CBPO,positive
218256.0,Credit Suisse Downgrades China Biologic Products To Neutral,2016-03-01 08:22:00-05:00,CBPO,positive
218257.0,Credit Suisse Downgrades China Biologic Products to Neutral Citing Fair Valuation,2016-03-01 06:01:00-05:00,CBPO,positive
218258.0,"Jefferies Maintains Buy on China Biologic Products, Lowers PT to $136.00",2016-02-29 06:59:00-05:00,CBPO,negative
218259.0,"China Biologic Sees FY16 Sales Growth 21-23%, Adj. EPS 24-26%",2016-02-25 18:06:00-05:00,CBPO,positive
218260.0,"China Biologic Reports Q4 EPS $0.74 vs. Est. $0.55, Rev. $68.3M vs. Est. $66.7M",2016-02-25 17:02:00-05:00,CBPO,neutral
218261.0,Mid-Afternoon Market Update: Oncomed Pharmaceuticals Slides After Poor Trial Data; Sunedison Shares Rise,2016-01-25 14:32:00-05:00,CBPO,negative
218262.0,Benzinga's Volume Movers,2015-12-22 10:19:00-05:00,CBPO,neutral
218263.0,Local China Drugmakers Gaining on Western Competition -Reuters,2015-11-29 09:43:00-05:00,CBPO,positive
218264.0,Marc Chan Reports 9.1% Passive Stake In China Biologic Products as of October 28,2015-11-05 15:38:00-05:00,CBPO,positive
218265.0,"China Biologic Reports Q3 Adj. EPS $0.94 vs $0.81 Est., Sales $78.8M vs $75.3M Est.; Raises FY15 Adj. Net Income Outlook",2015-11-03 17:09:00-05:00,CBPO,neutral
218266.0,"Amplewood Resources Reports 9.3% Passive Stake in China Biologic Products as of October 13, 2015",2015-10-20 14:40:00-04:00,CBPO,positive
218267.0,China Biologic Receives Operating Permit for New Branch Collection Facility in Shandong Province China,2015-10-20 08:33:00-04:00,CBPO,neutral
218268.0,Top 4 Mid-Cap Stocks In The Biotechnology Industry With The Highest EPS Growth Forecast For Next 5 Years,2015-09-14 04:53:00-04:00,CBPO,positive
218269.0,China Biologic Enters into Strategic Partnership Agreement to Source Raw Materials,2015-09-02 08:30:00-04:00,CBPO,positive
218270.0,"China Biologic Products Reports Q2 Adj. EPS $1.05 vs $0.87 Est., Sales $79.1M vs $71.8M Est.",2015-08-05 17:01:00-04:00,CBPO,neutral
218271.0,"Bank of America Initiates Coverage on China Biologic Products at Buy, Announces $135.00 PT",2015-07-09 07:57:00-04:00,CBPO,neutral
218272.0,China Biologic Prices 3M Offering At $105/SHare,2015-06-10 08:59:00-04:00,CBPO,neutral
218273.0,China Biologic Receives Approval to Purchase Raw Materials,2015-04-16 08:00:00-04:00,CBPO,positive
218274.0,China Biologic Products Reports Q4 EPS $0.56 Vs Est $0.51,2015-03-04 17:00:00-05:00,CBPO,neutral
218275.0,China Biologic Announces Shareholder Rights Plan,2015-01-08 17:00:00-05:00,CBPO,neutral
218276.0,China Biologic Receives GMP Certification For New Facility,2014-12-23 08:33:00-05:00,CBPO,neutral
218277.0,"China Biologic Products, Inc. Reports Q3 EPS of $0.81 vs $0.64 Est; Revenue of $68.92M vs $62.70M Est",2014-11-05 17:02:00-05:00,CBPO,neutral
218278.0,China Biologic Receives Approval for Commercial Manufacturing of Human Prothrombin Complex Concentrate at Shandong Taibang Facility ,2014-10-17 08:31:00-04:00,CBPO,positive
218279.0,"Aegis Capital Reiterates Buy on China Biologic Products, Inc., Raises PT to $59.00",2014-09-03 11:06:00-04:00,CBPO,neutral
218280.0,China Biologic Increases Equity Stake in Guizhou Taibang by 19.84% For $87.1M,2014-08-25 07:32:00-04:00,CBPO,neutral
218281.0,"China Biologic Products, Inc. Reports Q2 EPS of $0.82, Up 55% YOY; Revenue of $60.10M vs $56.27M Est",2014-08-05 16:46:00-04:00,CBPO,neutral
218282.0,Morgan Stanley Comments On China Biologic Products; Shares Rise,2014-07-08 14:03:00-04:00,CBPO,positive
218283.0,Benzinga's Volume Movers,2014-07-08 10:15:00-04:00,CBPO,neutral
218284.0,China Biologic Prices 1.55M Share Offering at $38/Share,2014-06-27 09:13:00-04:00,CBPO,positive
218285.0,"CBPO Reduces Offering by Selling Shareholder From 1M to 750,000 Shares",2014-06-27 07:34:00-04:00,CBPO,positive
218286.0,"China Biologic Announces Favorable Reduction in Value Added Tax Rate, VAT Rate on Blood Reduced from 6% to 3%",2014-06-23 07:33:00-04:00,CBPO,positive
218287.0,"China Biologic Release Confirms Offering of 1M Shares by Co., ~2.12M Shares by Selling Holders",2014-06-17 17:16:00-04:00,CBPO,positive
218288.0,"Filing from China Biologic Shows Registration for 3.2M Shares, 1M Through Co., 2.2M Shares Through Selling Holders",2014-06-17 16:59:00-04:00,CBPO,positive
218289.0,Mid-Morning Market Update: Markets Edge Higher; Tyson Wins Bidding Battle To Buy Hillshire Brands For $63/Share,2014-06-09 10:12:00-04:00,CBPO,positive
218290.0,China Biologic Files $120M Mixed Securities Shelf,2014-06-06 17:20:00-04:00,CBPO,positive
218291.0,UPDATE: Jefferies Initiates Coverage On China Biologic Products On Market Leader Position,2014-05-22 09:36:00-04:00,CBPO,neutral
218292.0,"Jefferies Initiates Coverage on China Biologic Products, Inc. at Buy, Announces $52.00 PT",2014-05-22 06:34:00-04:00,CBPO,neutral
218293.0,"China Biologic Products, Inc. Reports Q1 EPS of $0.73 vs $0.47 Est; Revenue of $56.30M vs $51.40M Est",2014-05-06 17:01:00-04:00,CBPO,neutral
218294.0,Mid-Afternoon Market Update: Markets Turn Red as Dish Network Rises,2014-03-26 15:46:00-04:00,CBPO,neutral
218295.0,Mid-Day Market Update: Five Below Jumps On Upbeat Results; Exelixis Shares Decline,2014-03-26 12:28:00-04:00,CBPO,positive
218296.0,"Oppenheimer Initiates Coverage on China Biologic Products, Inc. at Outperform, Announces $46.00 PT",2014-03-14 08:27:00-04:00,CBPO,neutral
218297.0,Form 8-K from China Biologic Products Shows Buyback Plan for 2.5M Shares with Siu Ling Chan,2014-01-28 08:09:00-05:00,CBPO,positive
218298.0,"Aegis Capital Downgrades China Biologic Products, Inc. to Hold",2013-11-06 15:05:00-05:00,CBPO,neutral
218299.0,China Biologic Issues Update on Hong Kong Litigation,2013-06-03 06:45:00-04:00,CBPO,negative
218300.0,China Biologic Says Company had No Prior Knowledge of Proposed Shanghai RAAS Transaction ,2013-05-24 06:48:00-04:00,CBPO,negative
218301.0,"China Biologic Products, Inc. Reports Q1 EPS of $0.59 vs $0.46 Est; Revenue of $54.0M vs $50.10M Est",2013-05-08 17:22:00-04:00,CBPO,neutral
218302.0,"Three Top Performing BRIC Stocks (CBPO, GSH, VIPS)",2013-03-17 15:13:00-04:00,CBPO,positive
218303.0,"UPDATE: Aegis Capital Maintains China Biological Products at Buy, Raises PT on 4Q Earnings",2013-03-14 15:44:00-04:00,CBPO,negative
218304.0,"China Biologic Products, Inc. Reports Q4 EPS of $0.21, Up 17% YOY; Revenue of $34.0M vs $45.0M Est",2013-03-13 17:28:00-04:00,CBPO,neutral
218305.0,"Top Narrow Based Indexes For January 15, 2013",2013-01-15 10:47:00-05:00,CBPO,positive
218306.0,"UPDATE: Aegis Capital Reiterates Buy Rating, Raises PT on China Biologic Products",2013-01-11 10:31:00-05:00,CBPO,neutral
218307.0,"Aegis Capital Maintains Buy on China Biologic Products, Inc., Raises PT to $22.00",2013-01-11 09:31:00-05:00,CBPO,neutral
218308.0,Morning Market Losers,2013-01-02 10:28:00-05:00,CBPO,negative
218309.0,Stocks Hitting 52-Week Highs,2012-12-28 11:14:00-05:00,CBPO,neutral
218310.0,Aegis Evaluates Chinese Bio Firms,2012-12-12 09:34:00-05:00,CBPO,neutral
218311.0,"UPDATE: Aegis Capital Initiates Coverage on China Biologic Products with Buy Rating, $20 PT",2012-12-12 08:41:00-05:00,CBPO,neutral
218312.0,"Aegis Capital Initiates Coverage on China Biologic Products, Inc. at Buy, Announces $20.00 PT",2012-12-12 08:22:00-05:00,CBPO,neutral
218313.0,China Biologic Raises FY Net Income Outlook from $38-40M to $46-48M,2012-11-08 16:48:00-05:00,CBPO,neutral
218314.0,China Biologic Products Reports Q3 EPS $0.54; Revenues $53.12M vs $45.00M Est,2012-11-08 16:47:00-05:00,CBPO,neutral
218315.0,China Biologic Receives SFDA Manufacturing Approval Certificate for Human Coagulation Factor VIII ,2012-06-25 08:30:00-04:00,CBPO,positive
218316.0,China Biologic Products Names Chairman David Gao to Additional Post of CEO ,2012-05-11 08:01:00-04:00,CBPO,neutral
218317.0,China Biologic Has Announced the Resignation of CFO Y. Tristan Kuo and Named Mr. Ming Yang as Interim CFO ,2012-04-27 16:31:00-04:00,CBPO,negative
218318.0,China Biologic's Board Has Appointed Two New Independent Directors to Boost Corporate Governance ,2012-04-25 06:38:00-04:00,CBPO,positive
218319.0,A Peek Into The Market Before The Trading Starts,2012-03-23 07:18:00-04:00,CBPO,neutral
218320.0,China Biologic Receives SFDA Approval to Begin Clinical Trials for Human Fibrinogen ,2012-03-23 06:45:00-04:00,CBPO,positive
218321.0,China Biologic Reports Q3 Revenue $41.3M vs $45.0M Est,2011-11-07 16:21:00-05:00,CBPO,neutral
218322.0,China Biologic Announces Changes in Directors ,2011-10-06 16:31:00-04:00,CBPO,neutral
218323.0,Friday's NASDAQ Top Gainers,2011-09-12 15:03:00-04:00,CBPO,positive
218324.0,China Biologic to Open Plasma Collection Station in Shandong Province ,2011-07-11 08:46:00-04:00,CBPO,neutral
218325.0,China Biologic Evaluating Possible Effects from a New Provincial Plan on Plasma Collection Stations in Guizhou Province,2011-07-11 08:31:00-04:00,CBPO,neutral
218326.0,China Biologic Products Expects 2010 EPS to Exceed the Guidance,2011-03-16 16:26:00-04:00,CBPO,neutral
218327.0,"China Biologic CEO Sells 200,000 Shares of CBPO",2010-09-09 16:45:00-04:00,CBPO,positive
218328.0,CBPO Q2 Results Beat Wall Street View,2010-08-16 06:10:00-04:00,CBPO,neutral
218329.0, 12 Stocks Insiders Are Buying ,2010-06-11 14:04:00-04:00,CBPO,neutral
